Recently, Nitsche et al discovered that there is a stage-dependent downregulation of PHLPP in pancreatic cancer patient specimens, thus suggesting a tumor suppressor role of PHLPP in pancreatic cancer [14]. This evidence concerns the gene PHLPP1 and familial pancreatic carcinoma.